RecruitingNot ApplicableNCT06847061

Pulmonary Rehabilitation for Rural Patients With COPD

Decreasing Disparity in Lung Disease: Pulmonary Rehabilitation for Rural Patients With COPD


Sponsor

Mayo Clinic

Enrollment

306 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to test the uptake, effectiveness, and patient-caregiver-provider experience of a crucial treatment not provided in rural areas: pulmonary rehabilitation.


Eligibility

Min Age: 40 Years

Inclusion Criteria5

  • years of age or older
  • Physician-diagnosed COPD
  • Living in a rural area defined by Rural-Urban Commuting Area Codes 4-10
  • mMRC score\>=1
  • English Speaking

Exclusion Criteria6

  • Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility)
  • Cognitive impairment or inability to understand and follow instructions.
  • Patients with no COPD symptom burden, no breathlessness (mMRC score 0), as based on our previous studies they usually perceive no benefit from PR and do not have compliance with PR.
  • Traditional center-based PR was completed within 3 months of initial study recruitment.
  • Transition to hospice or end-of-life care at the time of screening.
  • Acute exacerbation at the time of screening.

Interventions

BEHAVIORALPulmonary rehabilitation program

Participants are expected to engage in the home-based pulmonary rehabilitation routine at least 24 minutes a day, five to six days a week for the entire 12-week study period. The pulmonary rehabilitation routine begins with slow upper body and timed breathing exercises, followed by two slow balance walks for 6 minutes each. The total exercise time again is 24 minutes, followed by a 4-minute mindful breathing meditation/cool down


Locations(2)

Mayo Clinic in Arizona

Scottsdale, Arizona, United States

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06847061


Related Trials